Landmark Cars is a multi-brand automotive retailer in India that sells new and pre-owned luxury and premium vehicles, provides after-sales maintenance, and facilitates vehicle finance and insurance for brands like Mercedes-Benz, Honda, and Jeep.
The company possesses a narrow moat derived from its status as a preferred partner for global luxury OEMs and its high-margin after-sales service network, though low net margins (0.8%) and ROCE (10.8%) suggest limited pricing power against manufacturers and high competition.
Management has aggressively reinvested internal cash flows into network expansion, operationalizing 23 outlets in FY25, while maintaining a disciplined debt-to-equity ratio and initiating modest dividends.
The investment collapsed as the razor-thin 0.8% net margins proved insufficient to absorb rising interest costs on a 1.5 debt-to-equity load. While revenue grew, the negative EPS CAGR of -17.4% signaled a fundamental inability to scale profitably. The company eventually buckled under the weight of its aggressive network expansion when luxury demand softened, leaving it unable to service its debt with a meager 1.6 interest coverage ratio. The narrow moat of being a 'preferred partner' evaporated as OEMs squeezed dealer margins further, and the Supreme Court GST litigation resulted in a massive cash outflow that the company's weak balance sheet could not withstand.
RichFakir rates Landmark Cars Ltd's business quality as poor — 30/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Landmark Cars Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Landmark Cars Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now.
RichFakir's educational estimate of Landmark Cars Ltd's fair value is about ₹120 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →